The NHMRC didn't "move the goalposts"—it followed the exact international GRADE Evidence-to-Decision framework used across clinical medicine.
Low-certainty GRADE ratings are standard in paediatrics (50–80% of children's medications carry them because double-blind RCTs aren't ethical or feasible).
Evidence-to-Decision frameworks weigh the harm of inaction alongside clinical expertise, safeguards, and patient wellbeing—which is why medical bodies in Germany, France, Switzerland, Canada, and the US rejected blanket bans too.
Regulated care, not a free-for-all: The NHMRC backed conditional, multidisciplinary care with parental involvement—not unrestricted prescribing.
Opponents are mobilising to flood the NHMRC public consultation before 18 January 2027. If you are a healthcare worker, parent, or ally who supports evidence-based medicine, make sure your voice is heard too 👇
consultations.nhmrc.gov.au/c…
🚨 The @nhmrc review into puberty blockers reached the same conclusion as the UK, Sweden and Finland: the evidence for their use is low to very low quality.
But instead of restricting them like Queensland and the NT, the NHMRC moved the goalposts and gave them the green light.
I joined @RitaPanahi on @News24Aust to discuss the NHMRC's unsettling decision, my concerns about the panel, and what this means for medical research in Australia.
📢 Public consultation closes 18 January 2027. Have your say by visiting: consultations.nhmrc.gov.au/c…
#Auspol
1
107
In healthcare, few principles carry as much moral weight as "first, do no harm."
Yet in recent commentary attacking the NHMRC's guidance on puberty suppressants, that principle has been turned upside down—used as an excuse to justify denying regulated, evidence-based care to transgender and gender-diverse youth.
In Part 4, I break down the clinical and ethical reality behind that argument:
Inaction is not neutral: Withholding timely, regulated care forces young people with persistent gender incongruence through irreversible pubertal changes that intensify distress.
The Australian Charter of Healthcare Rights: Denying evidence-based care runs directly counter to patients' rights to Access, Safety, Respect, and Partnership in shared decision-making alongside their parents.
Preventative medicine doesn't wait for crisis: Under WHO (ICD-11) standards and the NHMRC framework, doctors don't force adolescents into acute psychiatric crisis before offering regulated, multidisciplinary support.
True ethical healthcare means standing alongside young people and their families before preventable harm takes hold.
Read the full article below 👇
Healthy public debate is a good thing—especially when it comes to healthcare. Parents, clinicians, and everyday readers deserve clear, honest discussions about medical evidence and patient safety.
Over the past few days, after sharing two evidence-based articles on paediatric medicine and regulated gender care, I saw firsthand where legitimate debate ends and social media's outrage machine takes over:
1. Slurs and defamatory smears replace substance when bad-faith accounts run out of medical arguments.
2. Copy-paste outrage and deflection bury clinical guidelines under noise.
3. Algorithms reward anger over accuracy, normalising cruelty toward real families and healthcare workers.
Stepping back reveals an important truth: the people throwing insults in the replies are never the real audience. The real audience is the silent majority scrolling past—the worried parents, young people, and everyday readers quietly looking for clear facts amidst all the noise.
In Part 3, I wrap up the series by looking at how online echo chambers distort medical discussions, why speaking up still matters, and how to set healthy boundaries to protect your peace online.
Read the full article below
When ideological lobby groups run out of clinical arguments, they resort to calling an internationally recognised WHO (ICD-11) and DSM-5-TR diagnosis "activist-crafted."
Here is what actually happened in Australia:
1. GRADE ratings aren't a scandal. Between 50% and 80% of all paediatric medications carry "low-certainty" ratings under GRADE because double-blind RCTs in children are rarely ethical or possible.
2. Regulated care, not a free-for-all. The NHMRC issued a conditional recommendation requiring thorough multidisciplinary assessment, parental consent, and ongoing clinical monitoring—aligning with national medical guidelines in Germany, Austria, Switzerland, France, Canada, and the US.
3. Evidence-based oversight. Australia's peak medical research body and Health Minister are following clinical evidence and specialist consensus rather than overseas political lobbying.
So Australia commissioned its own systematic reviews, the results came back (like every other in existence) showing low to very low quality evidence for puberty blockers.
Then they went ahead and recommended the drugs anyway, to fulfil the “embodiment goals” of physically healthy adolescents who have been given a nonsense, activist-crafted diagnosis.
And now the Health Minister is encouraging the states that have acted to protect kids from this medical scandal to follow the federal government's lead and once again give vulnerable kids these unproven drugs.
For years, Canada and Australia have been in close competition for which nation is the most shameful when it comes to all things gender. It's still too close to call, but I think Australia may have just edged into the lead.
This is a textbook example of stripping away clinical context to manufacture shock value:
1. Penile growth: Pausing male puberty prevents testosterone-driven penile growth. For a trans girl who does not want male virilisation, that is an expected physiological outcome that endocrinologists counsel patients and parents on upfront (specifically regarding future surgical options).
2. "Menopause-like state": GnRH analogues temporarily lower oestrogen to pre-pubertal levels—causing reversible symptoms like hot flushes while active, just as they do in precocious puberty. Once blockers stop or Stage 2 hormones begin, those symptoms resolve.
Publishing transparent GRADE data so clinicians, parents, and young people can weigh every known trade-off openly isn't a scandal—it's how ethical, evidence-based medicine works.
If a boy’s natural puberty is not blocked with drugs, he can expect to grow up as an adult with a penis 12.8cm long.
With chemical suppression of his normal sexual development courtesy of a children’s hospital gender clinic, he can expect his penis to end up 3.3cm shorter.
The evidence for this is of “moderate certainty”, according to Australia’s National Health and Medical Research Council.
And the NHMRC wants us to know the evidence that puberty blockers put girls into a menopause-like state is even better; it is of high certainty.
This is the kind of evidence cited by the NHMRC to promote business as usual at youth gender clinics, where kids as young as 10 can be put on puberty blockers.
And Australia’s Health Minister Mark Butler says we should listen to the NHMRC as the “pre-eminent authority”.
Full article at link below …
My recent post on puberty blockers and paediatric care proved one thing: online threads are flooded with the exact same recycled myths.
Working in healthcare, here is a quick clinical fact-check of the top 7 claims circulating online:
1. "It's like giving insulin to a non-diabetic."
False analogy. Insulin in a non-diabetic treats nothing and causes acute harm. GnRH analogues treat a recognised clinical diagnosis (ICD-11 / DSM-5-TR) using the exact same hormone-pausing mechanism used in precocious puberty.
2. "Blockers are temporary for precocious puberty, permanent for trans youth."
Stage 1 puberty blockers are a temporary pause. If stopped, endogenous puberty resumes. Stage 2 hormones are a separate clinical decision years later (typically around age 16) after further multidisciplinary and parental consent.
3. "Pausing puberty permanently stunts brain development."
There is no clinical evidence showing permanent cognitive or intellectual impairment in humans treated with puberty blockers.
4. "Blockers lead directly to surgeries on children."
In Australian public paediatric care, surgeries are not performed on under-18s. Conflating reversible hormone suppression with adult surgeries is pure scaremongering.
5. "Most kids outgrow gender dysphoria."
That claim relies on outdated 1980s/90s studies that counted tomboys and gender-nonconforming kids who never identified as trans. For youth meeting modern clinical criteria at puberty, over 95% remain trans into adulthood.
6. "Just use therapy instead."
Psychological and family support is already the foundation of Australian care—not an alternative. Therapy alone cannot stop unwanted biological puberty when severe dysphoria escalates.
7. "Detransitioners prove blockers should be banned."
Detransitioners deserve compassion and support, and their stories highlight why thorough multidisciplinary screening matters—not why care should be banned. Medicine improves screening for the 1–3% who experience regret; it does not outlaw vital care for the 97–99% who benefit.
Regulated paediatric healthcare belongs with young people, parents, and specialist medical teams—not social media outrage. Full breakdown in my Part 2 article 👇
Jennifer Buckley retweeted
Happy 60th birthday to Monolith Soft Founder and Chief Creative Officer Tetsuya Takahashi.
Monolith Soft has become vitally important to Nintendo and with Xenoblade Genesis coming next year, I hope we hear from him more!
Working in healthcare, it's alarming seeing paediatric care distorted online. Here is the clinical reality behind puberty blockers, off-label prescribing, regret rates, and why Australian medical bodies back regulated care 👇
With the current debate on puberty blockers for transgender and gender diverse youth there is so much misinformation and disinformation that is being posted on social media and in the media and is very alarming.
The fact is puberty blockers are safe, and they are effectives and we know this because they are used in treating other medical conditions in children and these children have then grown up to be adults and been fertile. They also don't become unsafe because they are being used for a different medical condition such as gender dysphoria and using them for gender dysphoria is also not child abuse.
The other fact is all of these opponents do not seem to understand the reality of paediatric medicine, where much of the medications are prescribed to young people is off-label and/or lacks long-term data as it is unethical to withhold treatments especially those that are lifesaving.
There is a strong double-standard that has been created by opponents to gender affirming care as a way to claim that medication or treatment like puberty blockers are somehow dangerous for transgender and gender diverse youth but not when being used to treat other medical conditions.
Another argument I hear is "they can't decide" well actually, including the young person into their medical treatment is done across all levels of medicine, even in my field of paramedicine. Just because they are young, doesn't mean that they can have a voice on what treatment they want. They don't get to make the decision on their own, as it is done in most cases with their parents and based on the clinical assessment and clinical evidence around the treatment. So, the whole argument off "they can't decide" or "they are too young to make this choice" is a false narrative that is being pushed.
I thoroughly enjoyed this and just playing around in this. It is so simple yet so much fun. I encourage everyone to have a go at it.
wow honestly out of words, thank you all 🙏
to celebrate I dropped some updates: dogfights, crashes, explosions, tutorials, gamepad support + a few other tricks
also decided to build the real game, you may want to stick around for that one
remix.ui8.ai/fly
53
Jennifer Buckley retweeted
Excellent outcome announced by Mark Butler today from the NHMRC’s review into transgender healthcare for children (interim guidance on the use of puberty blockers).
The full treatment guidelines for transgender care are expected to be released in early 2028.
Hopefully this will encourage all states to consider the evidence-based approach from the NHMRC, rather than adopting a political one.
Health Minister Mark Butler has challenged states and territories that have banned puberty blockers for children to comply with new national guidelines, which recommended gender-diverse teens get access to the treatment.
smh.com.au/politics/federal/…
Here in Australia, today the National Health and Medical Research Council (NHMRC) has released their advice for puberty suppressants for transgender and gender diverse youth and they are also developing national clinical guidelines to support safe, appropriate and person-centred care for trans and gender diverse people aged under 18.
To keep it simple and I have linked their press release here, they recommend puberty suppressants as a treatment for young people who have commenced puberty and are assessed as suitable by THEIR clinicians, in partnership with parents, carers and the young person themselves. They also recognized that delaying treatment as puberty progresses can affect a young person’s physical and mental health, well-being and ability to function.
This is such great news to come out during Trans Awareness Week.
nhmrc.gov.au/about-us/news-c…
Today is the beginning on Transgender Awareness week. An important week for me as awareness and facts are needed more than ever especially with Gender Affirming Care being banned in Qld public Gender Clinics (not private thankfully) which limits the access to vital healthcare services for transgender and gender diverse youth. There is disinformation and misinformation out there about transgender people, their healthcare as well as fictious medicine being promoted.
Transgender and gender diverse is a normal part of human diversity and this week we can celebrate this diversity.
🤖 Made with AI
1
70
I do hope something comes from this and happens. EA are notorious for buying studio's and when they interfere and the studio doesn't perform then they close them and then refuse to do anything with the IP. If this happens and they ate successfully in obtaining the IP, then at least Mass Effect and Dragon Age could live on.
BioWare co-founder Trent Oster has said he's looking into the possibility of getting the rights to BioWare's IP, and former Star Wars KOTOR and Dragon Age Origins creative director James Ohlen has confirmed his interest in joining him.
videogameschronicle.com/news…
53



















